Unicycive Therapeutics Revenue Growth & History (UNCY)

Unicycive Therapeutics reported $675,000 in revenue for fiscal 2023, a decrease of 29.02% from the previous fiscal year.

View full Unicycive Therapeutics company overview

Unicycive Therapeutics annual revenue and growth

Unicycive Therapeutics annual revenue

Fiscal yearPeriod endedRevenueChangeGrowth
20232023-12-31$675,000−$276,000−29.02%
20222022-12-31$951,000
About the data

What revenue means

Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.

Primary source

SEC company filings

TickerStat standardizes reported company facts from SEC EDGAR. Derived growth rates use the displayed revenue values and are not company guidance or forecasts.

Review Unicycive Therapeutics filings at SEC.gov ↗